Aquestive Therapeutics, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Aquestive Therapeutics, Inc. (AQST) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $591.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2019-03-14
- 2018-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $591.00K.
- 2017-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $0.00.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2018-12-31 | $591.00K 10-K · filed 2019-03-14 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |